255 related articles for article (PubMed ID: 31440027)
41. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2.
Li A; Jiao X; Munier FL; Schorderet DF; Yao W; Iwata F; Hayakawa M; Kanai A; Shy Chen M; Alan Lewis R; Heckenlively J; Weleber RG; Traboulsi EI; Zhang Q; Xiao X; Kaiser-Kupfer M; Sergeev YV; Hejtmancik JF
Am J Hum Genet; 2004 May; 74(5):817-26. PubMed ID: 15042513
[TBL] [Abstract][Full Text] [Related]
42. PREDICTED PROTEIN STRUCTURE VARIATIONS INDICATE THE CLINICAL PRESENTATION OF CYP4V2-RELATED BIETTI CRYSTALLINE DYSTROPHY.
Chan LW; Sung YC; Wu DC; Chen CY; Yang CH; Yang CM; Chen PL; Chen TC
Retina; 2022 Apr; 42(4):797-806. PubMed ID: 34923510
[TBL] [Abstract][Full Text] [Related]
43. Corneal deposits and nerve alterations in Bietti Corneoretinal Crystalline Dystrophy imaged using in vivo confocal microscopy.
Dai H; Zhang Y; Wu X; Li Y; Wang L; Li G
Graefes Arch Clin Exp Ophthalmol; 2023 Jul; 261(7):1941-1949. PubMed ID: 36786828
[TBL] [Abstract][Full Text] [Related]
44. Structural and functional phenotypic features and molecular analysis of Indian patients with Bietti crystalline dystrophy.
Ratra D; Chattree S; Raviselvan M; Pradhan A; Giridhar S
Indian J Ophthalmol; 2022 Jul; 70(7):2526-2532. PubMed ID: 35791149
[TBL] [Abstract][Full Text] [Related]
45. AAV2-mediated gene therapy for Bietti crystalline dystrophy provides functional CYP4V2 in multiple relevant cell models.
Wang JH; Lidgerwood GE; Daniszewski M; Hu ML; Roberts GE; Wong RCB; Hung SSC; McClements ME; Hewitt AW; Pébay A; Hickey DG; Edwards TL
Sci Rep; 2022 Jun; 12(1):9525. PubMed ID: 35680963
[TBL] [Abstract][Full Text] [Related]
46. An Overview of Rare and Unusual Clinical Features of Bietti's Crystalline Dystrophy.
Osman Saatci A; Can Doruk H
Med Hypothesis Discov Innov Ophthalmol; 2014; 3(2):51-6. PubMed ID: 25738160
[TBL] [Abstract][Full Text] [Related]
47.
Darki F; Fekri S; Farhangmehr S; Ahmadieh H; Dehghan MH; Elahi E
J Curr Ophthalmol; 2019 Jun; 31(2):172-179. PubMed ID: 31317096
[TBL] [Abstract][Full Text] [Related]
48. Identification of CYP4V2 mutation in 21 families and overview of mutation spectrum in Bietti crystalline corneoretinal dystrophy.
Xiao X; Mai G; Li S; Guo X; Zhang Q
Biochem Biophys Res Commun; 2011 Jun; 409(2):181-6. PubMed ID: 21565171
[TBL] [Abstract][Full Text] [Related]
49. Detailed phenotypic and genotypic characterization of bietti crystalline dystrophy.
Halford S; Liew G; Mackay DS; Sergouniotis PI; Holt R; Broadgate S; Volpi EV; Ocaka L; Robson AG; Holder GE; Moore AT; Michaelides M; Webster AR
Ophthalmology; 2014 Jun; 121(6):1174-84. PubMed ID: 24480711
[TBL] [Abstract][Full Text] [Related]
50. [Generation and characterization of
Jia RX; Jiang SW; Zhao L; Yang LP
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1099-1106. PubMed ID: 34916689
[TBL] [Abstract][Full Text] [Related]
51. Genotype-phenotype analysis of Bietti crystalline dystrophy in a family with the CYP4V2 Ile111Thr mutation.
García-García GP; López-Garrido MP; Martínez-Rubio M; Moya-Moya MA; Belmonte-Martínez J; Escribano J
Cornea; 2013 Jul; 32(7):1002-8. PubMed ID: 23538635
[TBL] [Abstract][Full Text] [Related]
52. Longitudinal structure-function analysis of molecularly-confirmed CYP4V2 Bietti Crystalline Dystrophy.
Cheloni R; Clough N; Jackson D; Moosajee M
Eye (Lond); 2024 Apr; 38(5):853-862. PubMed ID: 37898718
[TBL] [Abstract][Full Text] [Related]
53. In vivo confocal microscopic findings of 2 patients with Bietti crystalline corneoretinal dystrophy.
Bozkurt B; Ozturk BT; Kerimoglu H; Irkec M; Pekel H
Cornea; 2010 May; 29(5):590-3. PubMed ID: 20299976
[TBL] [Abstract][Full Text] [Related]
54. Identification, isolation, and characterization of a 32-kDa fatty acid-binding protein missing from lymphocytes in humans with Bietti crystalline dystrophy (BCD).
Lee J; Jiao X; Hejtmancik JF; Kaiser-Kupfer M; Chader GJ
Mol Genet Metab; 1998 Oct; 65(2):143-54. PubMed ID: 9787106
[TBL] [Abstract][Full Text] [Related]
55. Role of red free imaging, retinal reflectance and fundus autofluorescence in Bietti crystalline dystrophy: case report.
Surve A; Balaji A; Azad SV; Kumar V; Vohra R; Venkatesh P
Ther Adv Rare Dis; 2020; 1():2633004020958013. PubMed ID: 37180496
[TBL] [Abstract][Full Text] [Related]
56. [Progress in the studies of molecular genetics in Bietti crystalline corneoretinal dystrophy].
Xu F; Sui RF; Dong FT
Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):948-51. PubMed ID: 23302251
[TBL] [Abstract][Full Text] [Related]
57. Identification and population history of CYP4V2 mutations in patients with Bietti crystalline corneoretinal dystrophy.
Jiao X; Li A; Jin ZB; Wang X; Iannaccone A; Traboulsi EI; Gorin MB; Simonelli F; Hejtmancik JF
Eur J Hum Genet; 2017 Apr; 25(4):461-471. PubMed ID: 28051075
[TBL] [Abstract][Full Text] [Related]
58. Choroidal Vasculature in Bietti Crystalline Dystrophy With CYP4V2 Mutations and in Retinitis Pigmentosa With EYS Mutations.
Hirashima T; Miyata M; Ishihara K; Hasegawa T; Sugahara M; Ogino K; Yoshikawa M; Hata M; Kuroda Y; Muraoka Y; Ooto S; Yoshimura N
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3871-3878. PubMed ID: 28763560
[TBL] [Abstract][Full Text] [Related]
59. UTILIZATION OF FUNDUS AUTOFLUORESCENCE, SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY, AND ENHANCED DEPTH IMAGING IN THE CHARACTERIZATION OF BIETTI CRYSTALLINE DYSTROPHY IN DIFFERENT STAGES.
Li Q; Li Y; Zhang X; Xu Z; Zhu X; Ma K; She H; Peng X
Retina; 2015 Oct; 35(10):2074-84. PubMed ID: 25978730
[TBL] [Abstract][Full Text] [Related]
60. High-Resolution Imaging of Patients with Bietti Crystalline Dystrophy with CYP4V2 Mutation.
Gocho K; Kameya S; Akeo K; Kikuchi S; Usui A; Yamaki K; Hayashi T; Tsuneoka H; Mizota A; Takahashi H
J Ophthalmol; 2014; 2014():283603. PubMed ID: 25276414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
